NASDAQ
Creative Medical Technology Holdings, Inc. (CELZ) has a price/sales ratio of 778.38x as of Friday, May 22, 2026. This represents a 172.04% increase compared to its 12-month average of 286.13x. The price-to-sales ratio evaluates a company's stock price relative to its revenue, useful for valuing companies with little or no earnings.
No price data available for this timeframe.